Sort by
Refine Your Search
-
(3 required). Please provide the names and contact details for three referees who can comment knowledgeably about your expertise and potential fit for the post. Stanford is an equal opportunity
-
patients about why engineered cellular immunotherapies succeed or fail in patients. A successful candidate will leverage the hub’s multimodal data assets and model prototypes to build state-of-the-art
-
to improve health equity. Enthusiastic about infectious diseases and global public health. Required Application Materials: Cover letter that describes your research interests, scientific skillset and its
-
-Centered AI? HAI thinks about "Human-Centered AI" through three focus areas (link is external) . One representative writing sample (published or unpublished) Stanford is an equal opportunity employer and all
-
. Applicants with experience in proteomics and MS method development who are interested in applying their skills towards this challenge alongside learning more about (1) functional genomics, (2) molecular and
-
advancement of Human-Centered AI? HAI thinks about "Human-Centered AI" through three focus areas (link is external) . One representative writing sample (published or unpublished) Stanford is an equal
-
influences endothelial responses to hypoxia and shear stress Exploring pericyte-driven immune responses in the lung vasculature Are you passionate about groundbreaking research in pulmonary vascular diseases
-
would include: Co-developing a hybrid machine learning/process-based model of anaerobic digestion processes Performing techno-economic and lifecycle analysis of microgrids build around novel biogas-fueled
-
rolling basis. Those advancing will be notified and may be asked to submit additional materials, including letters of recommendation, and may be invited to interview. Please do not send emails asking about
-
to public health Women’s health and gender science Dismantling inequities in sports medicine Building the scientific evidence base about wellbeing through observational, intervention and biomarker research